Therapeutics: Histone deacetylase (HDAC); DNA (cytosine-5-)-methyltransferase 1 (DNMT1)

Cancer

INDICATION: Breast cancer

Patient sample, cell and mouse studies suggest combining inhibitors of HDAC and DNMT1 could help treat breast cancer. In

Read the full 217 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE